BIM
AVXL icon

BlackRock Investment Management’s Anavex Life Sciences AVXL Stock Holding History

BlackRock Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$502K Hold
126,696
– – ﹤0.01% 3048
2016
Q3 		$460K Sell
126,696
-326
-0.3% -$1.37K ﹤0.01% 3078
2016
Q2 		$776K Buy
+127,022
New +$614K ﹤0.01% 2810

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BlackRock Investment Management's AVXL Position: Q4 2016 in Review

BlackRock Investment Management held its Anavex Life Sciences (AVXL) position steady in Q4 2016 at 126,696 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #3048.

BlackRock Investment Management first reported a position in AVXL in Q2 2016 and has held it in 3 quarters since. The position peaked at $776K in Q2 2016. 59 funds tracked by Wall St. Rank hold AVXL as of Q4 2016.

  • BlackRock Investment Management held 126,696 shares of Anavex Life Sciences worth $502K as of Q4 2016.
  • BlackRock Investment Management left its Anavex Life Sciences share count unchanged in Q4 2016.
  • Anavex Life Sciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3048 holding.
  • BlackRock Investment Management first reported a position in Anavex Life Sciences in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Investment Management's Anavex Life Sciences position peaked at $776K in Q2 2016.
  • 59 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.